Evaluation of vascular hemodynamics in alveolar bone post exodonty in vivo through experimental endoscopic imagenology: pilot study

ISRCTN ISRCTN62029058
DOI https://doi.org/10.1186/ISRCTN62029058
Secondary identifying numbers DIUFRO project Nº DI17-0170
Submission date
29/08/2019
Registration date
08/09/2019
Last edited
05/09/2019
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Oral Health
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Background and study aims
Endoscopy has seen significant development over recent years in various medical fields with its application expanding from the support of minimal invasive surgery to in situ imaging. In this context, the application of endoscopic techniques to assess the quality of the regenerated bone in situ in the drill hole before implant placement is an appealing approach. The aim of this study is to use short distance support immersion endoscopy (SD-SIE) to compare the quality of regenerated bone in healed post-extraction sites, which are grafted with an in situ hardening β-TCP, against un-grafted sites, before implant placement. This assessment is based on microscopic bone analysis in combination with the blood vessel count.

Who can participate?
Two groups of patients with ages ranging from 18 to 85, including male and female patients, with native bone (extraction performed without graft material) and regenerated bone (extraction performed with graft material four to six months before the implantation), evaluated at the time of implant cavity preparation

What does the study involve?
Implant sites are assessed using SD-SIE, including blood vessels, mineralised area, non-mineralised area and the amount of resting bone substitute.

What are the possible benefits and risks of participating?
Endoscopic observation allows the detection of possible intraoperative accidents during implant preparation such as bone wall perforation, accidental contact with neurovascular structures and detection of foreign objects. Associated risks during the surgery are the same as with any tooth extraction such as pain and bleeding after the surgery and allergy against the anaesthesia.

Where is the study run from?
Implant Clinic of the Dental School of Universidad de La Frontera, Temuco (Chile)

When is the study starting and how long is it expected to run for?
March 2017 to October 2018

Who is funding the study?
The study was supported with biomaterials from Sunstar Suisse SA, Etoy, Switzerland to the Universidad de La Frontera, Temuco, Chile. Universidad de La Frontera also funded the study via a grant (DIUFRO No. DI17-0170)

Who is the main contact?
Prof. Dr. Víctor Beltrán
victor.beltran@ufrontera.cl

Contact information

Dr Victor Beltran
Public

Claro Solar 115
Temuco
4780000
Chile

Phone +56 (0)9971258075
Email victor.beltran@ufrontera.cl

Study information

Study designPilot prospective case-control study
Primary study designObservational
Secondary study designCase-control study
Study setting(s)Hospital
Study typeDiagnostic
Scientific titleIn situ endoscopic analysis of vascular supply and regenerated alveolar bone in β-TCP grafted and un-grafted post extraction sites before implant placement: a prospective case-control study
Study objectivesThe aim of this study was to use short distance support immersion endoscopy (SD-SIE) to compare the quality of regenerated bone in healed post-extraction sites, which are grafted with an in situ hardening β-TCP, against un-grafted sites, before implant placement. This assessment was based on microscopic bone analysis in combination with the blood vessel count.
Ethics approval(s)Approved 15/03/2017, Universidad de La Frontera Ethics Committee (Postal address: 4780000; Tel: +56 (0)452325775; Email: cec@ufrontera.cl), Decision 118/16
Health condition(s) or problem(s) studiedDental implant in mandibular or maxillary sites
InterventionA total of 13 grafted and 13 un-grafted alveolar sites were analyzed with short distance support immersion endoscopy (SD-SIE) in the drill hole right before implant placement. The sites belonged to the anterior maxillary zone including premolars, canines and incisors. All participants’ data were anonymized to ensure confidentiality and the grafted and un-grafted groups were randomized for a blind analysis.

Vessels, mineralized and unmineralized zones are measured before implant placement by support immersion endoscopy (SD-SIE) to compare the quality of regenerated bone and healing in post-extraction sites.

The assessment is made based on microscopic bone analysis (SD-SIE) in combination with blood vessel count according to the following protocol: (1) Selection of the area of interest (AoI), (2) Screenshot of images after irrigation and cleaning, (3) Set of the scale bar according to the transversal diameter of the scope window (contact mode) at the center of the image and definition of the area of measurement using Image J software.

Vessels are identified by observing the original video recordings that were recorded by the endoscopic procedure in vivo after cleaning the bone surface with saline solution. The percentages were calculated from area of mm2 by: Unmineralized bone or vessels multiplied by 100 and then divided by the Area of Interest (AoI). The mineralized bone area is calculated from the difference of the AoI from the vessels area selected plus non-mineralized bone. Bright white areas are selected as Bone Substitute. Vessels are counted in a blinded manner. Sites with pulsatile extravasation from arterial vessels were excluded, if the AoI could not be cleansed sufficiently.
Intervention typeOther
Primary outcome measureThe implant sites were evaluated using SD-SIE after 4-6 months. SD-SIE was applied in drill holes before implant placement, and videos were taken from representative central buccal areas. Measured at a single timepoint.
Secondary outcome measuresVideo recordings analyzed using Image J software for:
1. Number of blood vessels per area (NBV)
2. Relative area of vessels (VA)
3. Relative area of mineralized bone (MBA)
4. Relative area of unmineralized bone (UMBA)
5. Relative area of bone substitute (BSA)
Measured at a single timepoint
Overall study start date15/03/2017
Completion date01/10/2018

Eligibility

Participant type(s)Patient
Age groupAdult
Lower age limit18 Years
SexBoth
Target number of participantsMinimal 8 patients
Key inclusion criteria1. Patients older than 18 years old
2. Total or partial dentition
3. Indication for a dental implant in adequately formed mandibular or maxillary sites without regenerated bone
4. Indication of a dental implant in mandibular or maxillary sites, previously regenerated
Key exclusion criteria1. Drug abuse
2. Systemic diseases
3. Purulent local inflammation
4. Severe cardiovascular diseases
5. Active orthodontic treatment
6. Heavy smokers (>10 cigarettes/day)
Date of first enrolment15/05/2017
Date of final enrolment01/05/2018

Locations

Countries of recruitment

  • Chile

Study participating centre

The Implant Clinic of the Dental School of Universidad de la Frontera (UFRO)
Claro Solar 115
Temuco
4780000
Chile

Sponsor information

Universidad de La Frontera, Temuco, Chile (DIUFRO project Nº DI17-0170)
University/education

Avenida francisco salazar 01145
Temuco
4780000
Chile

Phone +56 (0)45232 5000
Email cec@ufrontera.cl
Website http://cec.ufro.cl/
ROR logo "ROR" https://ror.org/04v0snf24

Funders

Funder type

Industry

The study was supported with biomaterial from Sunstar Suisse SA, Etoy, Switzerland (DIUFRO-DI17-0170)

No information available

Results and Publications

Intention to publish date01/12/2019
Individual participant data (IPD) Intention to shareYes
IPD sharing plan summaryAvailable on request
Publication and dissemination planBioMed Research International. The special issue: "Biomechanical Properties of Biomaterials/Scaffolds for Bone Tissue Regeneration"
IPD sharing planThe datasets generated during and/or analysed during the current study are/will be available upon request from Prof. Dr Víctor Beltrán (victor.beltran@ufrontera.cl), Prof. Dr Wilfried Engelke (wengelke@med.uni-goettingen.de) and Dr Márcio Lazzarini (lazzarini@em.mpg.de).

Editorial Notes

03/09/2019: Trial's existence confirmed by ethics committee.